Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A McGovern

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|January 21, 2011
Genotypic inference of HIV-1 tropism using population-based sequencing of V3Rachel A McGovern, P Richard Harrigan, Luke C Swenson
Expert Opinion on Medical Diagnostics|March 15, 2013
Trofile HIV co-receptor usage assayAndrew J Low, Rachel A McGovern, P Richard Harrigan
Plos One|June 25, 2014
"Deep" sequencing accuracy and reproducibility using Roche/454 technology for inferring co-receptor usage in HIV-1David J H F Knapp, Rachel A McGovern, Art F Y Poon, et al.
Antiviral Therapy|May 11, 2011
Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantiallyAlexander Thielen, Thomas Lengauer, Luke C Swenson, et al.
AIDS (London, England)|August 26, 2010
Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studiesRachel A McGovern, Alexander Thielen, Theresa Mo, et al.
Journal of Clinical Microbiology|November 24, 2012
Factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testingDavid J H F Knapp, Rachel A McGovern, Winnie Dong, et al.
AIDS (London, England)|August 12, 2011
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing dataArt F Y Poon, Rachel A McGovern, Theresa Mo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2012
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trialRachel A McGovern, Alexander Thielen, Simon Portsmouth, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2013
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpointRachel A McGovern, Jori Symons, Art F Y Poon, et al.
Antiviral Therapy|May 12, 2015
Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, CanadaKatherine J Lepik, Benita Yip, Rachel A McGovern, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|January 21, 2011
Genotypic inference of HIV-1 tropism using population-based sequencing of V3Rachel A McGovern, P Richard Harrigan, Luke C Swenson
Expert Opinion on Medical Diagnostics|March 15, 2013
Trofile HIV co-receptor usage assayAndrew J Low, Rachel A McGovern, P Richard Harrigan
Plos One|June 25, 2014
"Deep" sequencing accuracy and reproducibility using Roche/454 technology for inferring co-receptor usage in HIV-1David J H F Knapp, Rachel A McGovern, Art F Y Poon, et al.
Antiviral Therapy|May 11, 2011
Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantiallyAlexander Thielen, Thomas Lengauer, Luke C Swenson, et al.
AIDS (London, England)|August 26, 2010
Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studiesRachel A McGovern, Alexander Thielen, Theresa Mo, et al.
Journal of Clinical Microbiology|November 24, 2012
Factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testingDavid J H F Knapp, Rachel A McGovern, Winnie Dong, et al.
AIDS (London, England)|August 12, 2011
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing dataArt F Y Poon, Rachel A McGovern, Theresa Mo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2012
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trialRachel A McGovern, Alexander Thielen, Simon Portsmouth, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2013
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpointRachel A McGovern, Jori Symons, Art F Y Poon, et al.
Antiviral Therapy|May 12, 2015
Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, CanadaKatherine J Lepik, Benita Yip, Rachel A McGovern, et al.
Pageof 1